Please select the option that best describes you:
Topics:
Infectious Disease • HIV & AIDS
Would you consider using long-acting injectable cabotegravir/rilpivirine for pregnant women with HIV?
Answer from: at Academic Institution
At this time, long-acting injectable cabotegravir/rilpivirine (CAB/RPV) is not generally recommended during pregnancy due to limited safety data and unknown effects on the developing fetus. So far, there have not been any reported safety concerns regarding harm to the fetus for either long-acting in...
Sign in or Register to read more
Answer from: at Community Practice
Yes! I am part of a consortium for Southeast Michigan that treats pregnant women, and this injectable has been used many times with good outcomes. I think the Patel article (although small) shows low risk. Additional PBPK information was recently presented at CROI: Patel et al., CROI 2020.